Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Go back to Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 8.04 +0.38 (4.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.66 | 52 Week High | $82.81 | |||
| Open | $7.64 | 52 Week Low | $19.74 | |||
| Day High | $8.08 | P/E | N/A | |||
| Day Low | $7.57 | EPS | $-2.16 | |||
| Volume | 439,736 | |||||
